Perfusion Systems Market (Covid-19) Impact and Analysis By 2027 | REPLIGEN CORPORATION, Merck KGaA, Ala Scientific Instruments, XVIVO Perfusion, Medtronic, XENIOS AG (Fresenius Medical Care AG & Co. KGaA), Getinge AB, TERUMO CORPORATION and others

The Insight Partners analysts forecast the latest report on “Perfusion Systems Market (Covid-19) Impact and Analysis by 2027”, according to report; The Perfusion Systems Market report covers the overall and all-inclusive analysis of Market with all its factors that have an impact on market growth. This report is anchored on the thorough qualitative and quantitative assessment of the Perfusion Systems Market.

The study provides details such as the market share, Market Insights, Strategic Insights, Segmentation and key players in the Perfusion Systems Market.

Download Sample Report of Perfusion Systems Market Report @ https://www.theinsightpartners.com/sample/TIPMD00002293/?openpr-10225

(*If you have any special requirements, please let us know and we will offer you the report as you want.)

The perfusion systems market accounted to US$ 1,044.75 Mn in 2018 and is expected to grow at a CAGR of 3.8% during the forecast period 2019 - 2027, to account to US$ 1,442.28 Mn by 2027.

The List of Companies

REPLIGEN CORPORATION
Merck KGaA
Ala Scientific Instruments, Inc.
XVIVO Perfusion
Medtronic
XENIOS AG (Fresenius Medical Care AG & Co. KGaA)
TERUMO CORPORATION
Getinge AB
Harvard Bioscience
OrganOx

Emerging Players

Sartorius AG
RAND
LivaNova PLC
Sanisure (Sani-Tech West, Inc.)
AutoMate Scientific, Inc.
APD (Advanced Perfusion Diagnostics)
Spectrum Medical
Transonic Systems Inc
CESCO BIOENGINEERING CO., LTD.
Jobst Technologies GmbH
Market Insights

Rising Need for The Organ Transplantation is expected to boost the market growth over the years

Organ transplantation is a surgical process done when a patient’s organ has stopped functioning completely. The organ transplant is commonly done for the organs such as heart, liver and kidney. However, the rising cases of the chronic diseases are leading to the need of the transplantation for the other organs such as lung, pancreases, cornea, and vascular tissues among others. The organ transplantation surgeries are rising across the world. For instance, in Spain, approximately 5,260 transplant surgeries were performed, among which nearly 3,200 were kidney transplant and around 1,200 were liver transplant surgeries. The number of heart transplant surgeries were approximately 300 and lung were nearly 360. The public-private partnership in assistance with the transplant coordinators has enormously contributed to the improvement of the organ transplantation.

As per the National Chronic Kidney Disease fact sheet 2017, states that approximately, 30 million people in US are estimated to have chronic kidney diseases. Similarly, according to the National Institute id Diabetes and Digestive and Kidney Diseases states that nearly 661,000 Americans have kidney failure among these nearly, 468,000 patients are taking dialysis, and approximately 193,000 have undergone kidney transplantation. Therefore, the increasing incidences are likely to grow more needs for the kidney transplantation in the coming years. Likewise, it is estimated that the growing numbers of the heart diseases are also responsible to drive the market in coming futures.

Rising Cell Based Research Activities

The rise in the chronic diseases, advantages of the applications of biotechnology are growing the extensive cell based research activities. The cell based assays assists in understanding the challenges of biology of the living organisms. The cell based assays helps in the understanding the aspects such as cell signaling, proliferation, apoptosis, cellular genetics, neurology, cancer and more. The cell based assays are extensively carried out in pharmaceutical, biotechnology industries, research institutes and academics research institutes. The pharmaceutical and biopharmaceutical industries need to efficiently commercialize the drug. Therefore, cell based assays in the pharmaceutical and biotechnology industry are the driving factor for the growth of the perfusion systems.

The cell based assays are also extensively carried out by the contract research organization for the clinical trial studies and other processes. The chronic diseases such as cancer and other genetic related studies are enforcing for the cell based studies. For instance, Charles River offers services for the human primary cell based assays and according to an article published by the company states that the development in the cell based assays are likely to continue growing in the future.

Strategic Insights

Strategic acquisition and product launches were observed as the most adopted strategy in global perfusion systems industry. Few of the recent product launch, product approval and acquisitions are listed below:

2018: XVIVO Perfusion has submitted the Premarket Approval (PMA) application for the XPS with STEEN Solution to the FDA.

2019: Sartorius Stedim Biotech (Sartorius AG) launched ambr 250 high throughput (ht) perfusion, specially designed for rapid cell culture perfusion process development to optimize production of therapeutic antibodies.

2018: Spectrum Medical announced acquisition of the second exclusive licensing agreement with the University of California, Los Angeles (UCLA) Technology Development Group on behalf of UC Regents. The license is in association of the intellectual property that supports clinical applications requiring Extracorporeal Circulation.

MARKET SEGMENTATION

By Type

• Microfluidic Perfusion Systems
• Small-Mammal Organ Perfusion Systems
• Bioreactor Perfusion Systems
• Gravity or Pressure-Driven Perfusion Systems

By Component

• Perfusion Pumps
• Oxygenators
• Heart-Lung Machines
• Monitoring Systems
• Cannulas
• Others

The report analyses factors affecting the Perfusion Systems Market from further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Perfusion Systems Market in these regions.

Moreover, the report entails the estimate and analysis for the Perfusion Systems Market on a global as well as regional level. The study provides historical data as well as the trending features and future predictions of the market growth. Further, the report encompasses drivers and restraints for the Perfusion Systems Market growth along with its impact on the overall market development. In addition, the report provides an analysis of the accessible avenues in the market on a global level.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global Perfusion Systems Market based on various segments. It also provides market size and forecast estimates from the year 2018 to 2027 with respect to five major regions. The Perfusion Systems Market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

Promising Regions & Countries Mentioned in The Perfusion Systems Market Report:
• North America
• Europe
• Asia-Pacific
• Latin America
• The Middle East & Africa

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Major Features of Perfusion Systems Market Report:

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Perfusion Systems market
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the global Perfusion Systems market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution.

Purchase a copy of Perfusion Systems Market research report @ https://www.theinsightpartners.com/buy/TIPMD00002293/?openpr-10225

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, Chemical etc.

This release was published on openPR.